Daily non-political popular news in brief.
Green tea compound may be a therapy for people with rheumatoid arthritis
04-29-2007 · EurekAlert!A new study from the University of Michigan Health System suggests that a compound in green tea may provide therapeutic benefits to people with rheumatoid arthritis.
Read more »
Keywords: green, tea, compound, therapy, people, rheumatoid, arthritis, arthriti
« Previous | Next »
Similar news on "Green tea compound may be a therapy for people with rheumatoid arthritis":
- Green tea compound suppresses factors causing cartilage, bone destruction in arthritis
04-29-2007 · EurekAlert!
In rheumatoid arthritis, a person's own immune system attacks the joints by activating the synovial tissue that lines the body’s movable joints, causing inflammation, swelling, pain and eventually erosion of the bone and cartilage and deformation of the joint. Dr. Salah-uddin Ahmed reports that a compound derived from green tea was able to inhibit production of several immune system molecules involved in inflammation and joint damage.
Similar news · Read more »
- Enbrel safety data for up to 8 years in patients with juvenile rheumatoid arthritis
06-13-2007 · EurekAlert!
Amgen and Wyeth Pharmaceuticals, a division of Wyeth, today announced the presentation of additional data that showed that the safety profile of Enbrel was maintained with long-term use in patients with moderate-to-severe juvenile rheumatoid arthritis who completed up to eight years of therapy. The study results will be presented at the European League Against Rheumatism Annual Congress, an international rheumatology meeting, in Barcelona, Spain.
Similar news · Read more »
- Meditation therapy for rheumatoid arthritis patients
09-28-2007 · EurekAlert!
Mindfulness-based stress reduction shows promise for easing psychological distress associated with disease symptoms.
Similar news · Read more »
- The HLA-DRB1 gene and premature death in rheumatoid arthritis
01-31-2008 · EurekAlert!
People with rheumatoid arthritis, an inflammatory autoimmune disease, tend to die younger and, largely from cardiovascular disease.
Similar news · Read more »
- New treatments prevent brain injury hours after stroke in rats
12-28-2006 · EurekAlert!
Two novel treatments -- a basic compound found in every cell in the body and an extract of green tea -- may prevent brain damage caused from stroke, according to two studies in rats led by a researcher at the San Francisco VA Medical Center.
Similar news · Read more »
- Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
08-10-2007 · EurekAlert!
Concentrated chemicals derived from green tea dramatically boosted production of a group of key detoxification enzymes in people with low levels of these beneficial proteins, according to researchers at Arizona Cancer Center.
Similar news · Read more »
- One-fifth of patients in drug-free remission following early treatment with Infliximab and Methotrex
06-14-2007 · EurekAlert!
Early treatment with a combination of methotrexate and infliximab may be effective as remission induction therapy and alter the course of early rheumatoid arthritis, according to data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
Similar news · Read more »
- Green tea extract protects against brain damage in new mouse model of HIV-related dementia
05-01-2007 · EurekAlert!
A green tea extract may represent a new and natural compound for preventing and treating HIV-associated dementia, a study using a new mouse model for the devastating disease suggests.
Similar news · Read more »
- Tea compound aids dying brain cells
09-29-2007 · Science News Online
A constituent of green tea rescues brain cells damaged in a way that mimics the effect of Parkinson's disease.
Similar news · Read more »
- Experimental MS drug shows promise, offers new window on disease
02-13-2008 · EurekAlert!
A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial led by scientists at University of California-San Francisco.
Similar news · Read more »
